Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
Ruzzo, A, Graziano, F, Galli, Fabio, Galli, Francesca, Rulli, E, Lonardi, S, Ronzoni, M, Massidda, B, Zagonel, V, Pella, N, Mucciarini, C, Labianca, R, Ionta, M T, Bagaloni, I, Veltri, E, Sozzi, P, Barni, S, Ricci, V, Foltran, L, Nicolini, M, Biondi, E, Bramati, A, Turci, D, Lazzarelli, S, Verusio, C, Bergamo, F, Sobrero, A, Frontini, L, Menghi, M, Magnani, M
Published in British journal of cancer (24.10.2017)
Published in British journal of cancer (24.10.2017)
Get full text
Journal Article
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)
Di Nardo, P., Basile, D., Siciliano, A., Pelizzari, G., Corvaja, C., Buriolla, S., Ongaro, E., Maria Grazia, D., Garattini, S.K., Foltran, L., Guardascione, M., Casagrande, M., Buonadonna, A., Prantera, T., Aprile, G., Puglisi, F
Published in Digestive and liver disease (01.05.2024)
Published in Digestive and liver disease (01.05.2024)
Get full text
Journal Article
Unplanned presentations of cancer outpatients: a retrospective cohort study
Aprile, G., Pisa, F. E., Follador, A., Foltran, L., De Pauli, F., Mazzer, M., Lutrino, S., Sacco, C. S., Mansutti, M., Fasola, G.
Published in Supportive care in cancer (01.02.2013)
Published in Supportive care in cancer (01.02.2013)
Get full text
Journal Article
Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study
Giordano, G, Lo Re, G, Milella, M, Di Marco, M, Melisi, D, Passardi, A, Iop, A, Febbraro, A, Foltran, L, Francesca, B, Bertocchi, P, Vaccaro, V, Aloi, M.B, Giommoni, E, Ricci, V, Vasile, E, Zaniboni, A, Zagone, V, De Vita, F
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification
Saracchini, S, Foltran, L, Tuccia, F, Bassini, A, Sulfaro, S, Micheli, E, Del Conte, A, Bertola, M, Gion, M, Lorenzon, M, Tumolo, S
Published in Breast (Edinburgh) (01.12.2013)
Published in Breast (Edinburgh) (01.12.2013)
Get full text
Journal Article
534P Second-line treatment in older patients with metastatic colorectal cancer: The ELECTRA study
Cordua, A., Basile, D., Sperotto, S., Foltran, L., Casagrande, M., carullo, M., Morano, F., Lucchetti, J., Rosati, G., Avallone, A., Lai, E., Lutrino, E.S., Parnofiello, A., Guardascione, M., Leone, A.G., Zurlo, I.V., Conca, V., Leo, S., Lonardi, S., Aprile, G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
582P Prognostic role of macrophage infiltration and monocyte-to-lymphocyte ratio in stage III colon cancer: The MIRROR study
Basile, D., Polano, M., Di Nardo, P., Gallois, C., Garattini, S.K., ongaro, E., Foltran, L., Girimonte, D., Gerratana, L., Cortese, C., Marco, D.S., Cordua, A., Ventura, M., Pella, N., Zaanan, A., Aprile, G., Canzonieri, V., Taieb, J., Puglisi, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
498TiP Adjuvant trastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: The TRINITY trial
Nasca, V., Raimondi, A., Palermo, F., Morano, F., Bergamo, F., Foltran, L., Spallanzani, A., Brunetti, O., Spada, D., Tamberi, S., Antonuzzo, L., Cella, C.A., Avallone, A., Bencardino, K., Fornaro, L., Di Donato, S., Strippoli, A., Puccini, A., Tamburini, E., Pietrantonio, F.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
Abstract P1-03-08: New diagnostic tools for bone health assessment: Perspectives in medical oncology
Cosmi, F, Del Conte, A, Foltran, L, Nicolosi, A, Saracchini, S
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
T02.02.19 CLINICAL AND MOLECULAR CHARACTERIZATION OF A NEW KIT-MUTATED FAMILIAL GASTROINTESTINAL STROMAL TUMOR: A PRACTICAL APPROACH TO A RARE CONDITION
Campigotto, M., Foltran, L., Gasparotto, D., Maestro, R., Cannizzaro, R., Colombo, A., Visintin, A., Fornasarig, M.
Published in Digestive and liver disease (01.10.2020)
Published in Digestive and liver disease (01.10.2020)
Get full text
Journal Article
416P A novel prognostic tool based on lymphocyte ratios in patients with stage III colon cancer
Basile, D., Polano, M., Buriolla, S., Gallois, C., Cortiula, F., Corvaja, C., De Scordilli, M., Michelotti, A., Pelizzari, G., Ongaro, E., Casagrande, M., Foltran, L., Toffoli, G., Pella, N., Buonadonna, A., Zaanan, A., Fasola, G., Aprile, G., Taieb, J., Puglisi, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
P327 - BESTEST®: a new diagnostic opportunity for bone structure evaluation in oncology
Saracchini, S., Del Conte, A., Foltran, L., Corsetti, S., Cosmi, F.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
BESTEST®: a new diagnostic opportunity for bone structure evaluation in oncology
Saracchini, S., Del Conte, A., Foltran, L., Corsetti, S., Cosmi, F.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
P-266 LDH levels as predictors of efficacy in second-line treatment for metastatic gastric cancer: The LINE study
Michelotti, A., Ongaro, E., Gerratana, L., Scordilli, M. De, Di Nardo, P., Foltran, L., Guardascione, M., Basile, D., Cortiula, F., Miolo, G., Parnofiello, A., Bertoli, E., Lisanti, C., Buriolla, S., Buonadonna, A., Puglisi, F.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
P-246 Taxane cross-resistance: An exploratory analysis of second-line chemotherapy for metastatic gastric cancer
Di Nardo, P., Guardascione, M., Basile, D., Foltran, L., Ongaro, E., Miolo, G., Fanotto, V., Lisanti, C., Michele, B., Parnofiello, A., Cortiula, F., Bertoli, E., Buriolla, S., De Scordilli, M., Michelotti, A., Puglisi, F., Buonadonna, A.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
PO-1112: Total neoadjuvant therapy in high risk rectal cancer: a feasibility pilot study
Palazzari, E., Buonadonna, A., Lauretta, A., Navarria, F., Ongaro, E., Foltran, L., Innocente, R., Belluco, C., Ubiali, P., Canzonieri, V., Urbani, M., Colombo, C., Bertola, G., De Paoli, A.
Published in Radiotherapy and oncology (01.11.2020)
Published in Radiotherapy and oncology (01.11.2020)
Get full text
Journal Article
The SAFFO study: Sex-related prognostic role and cut-oFf deFinition of monocyte-to-lymphocyte ratio (MLR) in metastatic colOrectal cancer
Lisanti, C., Basile, D., Garattini, S.K., Parnofiello, A., Corvaja, C., Cortiula, F., Pelizzari, G., Cattaneo, M., Andreotti, V.J., Bertoli, E., Ongaro, E., Iacono, D., Foltran, L., Casagrande, M., Miolo, G., Cardellino, G.G., Fasola, G., Pella, N., Buonadonna, A., Puglisi, F.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article